THURSDAY, March 24, 2022 (HealthDay News) — Millions of people taking statin drugs to lower their cholesterol may get an unanticipated benefit: They may be less likely to develop movement and balance problems like those seen in Parkinson’s disease, a new study suggests. The study looked at the relationship betweenContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — Even though medication is considered the most effective therapy for opioid addiction, many Americans who need it don’t receive it, a new study finds. “Evidence supporting the effectiveness of medication for opioid use disorder — such as methadone, buprenorphine or naltrexone — isContinue Reading
THURSDAY, March 24, 2022 (HealthDay News) — A lower dose of a widely used COVID-19 drug is just as effective as a higher dose, new research shows. Tocilizumab (Actemra) is a rheumatoid arthritis drug that has become the standard of care for treating severe COVID-19, but high demand and productionContinue Reading
WEDNESDAY, March 23, 2022 (HealthDay News) — Moderna announced Wednesday that it will ask the U.S. Food and Drug Administration to approve the emergency use of its COVID-19 vaccine for children under 6. The company said that its request is based on interim results from its clinical trial that showed,Continue Reading
WEDNESDAY, March 23, 2022 (HealthDay News) — In a finding that could influence future COVID vaccine recommendations for the youngest Americans, new research finds that infants and toddlers have a stronger immune response to the new coronavirus than adults do. To arrive at that conclusion, scientists analyzed blood samples collectedContinue Reading
TUESDAY, March 22, 2022 (HealthDay News) — The party drug “ecstasy” might be the key to helping people heal from post-traumatic stress disorder (PTSD), new clinical trial results indicate. In a small study, PTSD patients treated with a powerful combination of the psychedelic drug, also known as MDMA, and talkContinue Reading
TUESDAY, March 22, 2022 (HealthDay News) — Medical marijuana could be a viable alternative to opioid painkillers for people dealing with arthritis or chronic back pain, two new studies show. Many patients prescribed opioids for their chronic pain wound up taking fewer painkillers — or stopping them altogether — afterContinue Reading
TUESDAY, March 22, 2022 (HealthDay News) — Antibodies from a COVID-19 infection linger in most children for up to seven months, even if they had no symptoms, a new study finds. To come to that reassuring conclusion, researchers analyzed data from 218 children in Texas, ages 5 to 19, whoContinue Reading
FRIDAY, March 18, 2022 (HealthDay News) — Using medical marijuana to treat pain, anxiety or depression may quickly lead to dependence, without relieving symptoms, a new study suggests. Those most at risk for misusing medical marijuana are patients using it to treat anxiety and depression, the researchers found. Based onContinue Reading
FRIDAY, March 18, 2022 (HealthDay News) — Moderna said late Thursday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster of its COVID vaccine for all adults. In a statement, the company noted its request is based partly on recentContinue Reading
THURSDAY, March 17, 2022 (HealthDay News) — In a finding that reinforces the safety of COVID vaccines, a new study shows that while the shots don’t raise the risk of rare neurological problems, COVID-19 infection might. The researchers focused on four immune-related neurological disorders: Bell’s palsy (facial weakness), encephalomyelitis (inflammationContinue Reading
WEDNESDAY, March 16, 2022 (HealthDay News) — Pfizer Inc. said Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster shot for Americans 65 and older. In a statement announcing its request, Pfizer relied on data from two studies outContinue Reading
MONDAY, March 14, 2022 (HealthDay News) — A new drug that can cure a certain type of malaria was approved in Australia Monday for kids and teens. The approval was announced on Monday by the nonprofit Medicines for Malaria Venture (MMV), which helped develop the drug with GlaxoSmithKline (GSK). ItContinue Reading
MONDAY, March 14, 2022 (HealthDay News) — Taken correctly, prescription drugs used to treat attention-deficit/hyperactivity disorder (ADHD) can help teens and young adults navigate their condition, but a new study finds many are dying from overdosing on these medications. In 2019, benzodiazepines like Xanax and stimulants like Adderall accounted forContinue Reading